Ex-major-leaguer indicted in med device insider trading scheme; Mindray's recall gets Class I label;

 @FierceMedDev: eBay co-founder invests heavily in India's medtech industry. Item | Follow @FierceMedDev

@MarkHFierce: Indictments filed in a long-standing med device insider trading case. An ex Angels ball player is involved. More | Follow @MarkHFierce

 @DamianFierce: With St. Jude's $1B stock repurchase, the company says the future will be stable. Do investors agree? Story | Follow @DamianFierce

> A former major league baseball player and three other people have been indicted for allegedly using insider-trading information to buy stock in Advanced Medical Optics, which Abbott Labs ($ABT) subsequently snatched up for $3 billion in 2009. Story

> Mindray Medical's ($MR) voluntary recall of anesthesia devices got slapped with a Class I label--the most serious--by the FDA. More

> NeuroMetrix ($NURO) won 510(k) clearance for a disposable electrode used with its Sensus pain management device--which allows the company to begin marketing the product in the U.S. Release

> Transcranial magnetic stimulation helped people with spinal cord injuries improve the use of their hands, according to a new study. Story

> Varian Medical Systems ($VAR) gained regulatory clearance from India's Atomic Energy Regulatory board to use the high-intensity mode of its TrueBeam medical linear accelerator for advanced radiosurgical treatments. Item

> Abiomed's ($ABMD) shareholder woes continue as it faces another class-action lawsuit, claiming it made false statements related to the safety of its Impella 2.5 device. News

> Tangent Medical Technologies, maker of a closed-system IV device, has raised $8.6 million to bring the tech to market. Report

> Devicemaker Verathon, which is owned by Roper ($ROP), is launching a voluntary recall of reusable blades in its GlideScope GVL video laryngoscope. Article

Biotech News

 @FierceBiotech: From FierceBiotechIT.com: Study: Genomics, outsourcing fuel double-digit growth in bioinformatics. Report | Follow @FierceBiotech

 @JohnCFierce: BioCryst ends a very bad, disastrous, no good of any kind of month by terminating merger pact. News | Follow @JohnCFierce

 @RyanMFierce: Sounds like adult blood could best skin cells as source for stem cells. We'll see. BBC report. More | Follow @RyanMFierce

> Big Pharma backers fuel $17M first round for developer of brain-penetrating protein drugs. Article

> Exelixis grabs first FDA nod for blockbuster hopeful against thyroid cancer. Story

Pharma News

@FiercePharma: Ranbaxy stops making generic Lipitor as news of 2nd recall surfaces. Story | Follow @FiercePharma

> Presidio, BioCryst call off $101 million merger. Item

> Theravance wins partial victory for Vibativ. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.